PKC-δ mediates interferon-α-induced apoptosis through c-Jun NH-terminal kinase activation

Noriko Yanase1, Miho Hayashida, Yuki Kanetaka-Naka

  • 1Department of Immunology and Intractable Immune System Disease Research Center, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan.

BMC Cell Biology
|March 23, 2012
PubMed
Abstract

Insights

Interferon-alfa (IFN-α) activates JNK1 through PKC-δ, upregulating TRAIL and inducing apoptosis in B lymphoma cells. This pathway is crucial for IFN-α

Area of Science:

  • Oncology
  • Cell Biology
  • Immunology

Background:

  • Interferon-alfa (IFN-α) exhibits anti-tumor properties, including apoptosis induction in B lymphoma cells.
  • IFN-α triggers sustained activation of c-Jun NH₂-terminal kinase1 (JNK1), a key player in tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) promoter activation.
  • The upstream signaling components responsible for prolonged IFN-α-induced JNK1 activation require elucidation.

Purpose of the Study:

  • To investigate the upstream signaling pathway mediating sustained JNK1 activation by IFN-α.
  • To determine the role of protein kinase C delta (PKC-δ) in IFN-α-induced JNK1 activation and subsequent apoptotic events.

Main Methods:

  • Western blotting to detect phosphorylated PKC-δ in IFN-α-treated B lymphoma and myeloma cells.
  • Utilized dominant-negative PKC-δ (dnPKC-δ) and PKC-δ inhibitor rottlerin to assess JNK1 activation, TRAIL promoter activity, and apoptosis markers.
  • Employed a constitutively active PKC-δ mutant to evaluate its effect on IFN-α-induced TRAIL promoter activity and mitochondrial membrane potential.

Main Results:

  • IFN-α activated PKC-δ in Daudi B lymphoma and U266 myeloma cells.
  • dnPKC-δ and rottlerin significantly attenuated IFN-α-induced JNK1 activation, TRAIL promoter activity, and apoptotic markers (loss of mitochondrial membrane potential, increased propidium iodide uptake).
  • Constitutively active PKC-δ enhanced IFN-α-induced TRAIL promoter activity and mitochondrial dysfunction, while dnPKC-δ abrogated IFN-α-induced Ser727 phosphorylation of Stat1.

Conclusions:

  • IFN-α activates JNK1 via PKC-δ, leading to TRAIL upregulation and subsequent apoptosis in B lymphoma cells.
  • The PKC-δ-mediated signaling pathway, including Stat1 phosphorylation, contributes to IFN-α-induced apoptotic events.
  • This study elucidates a novel signaling cascade involving PKC-δ and JNK1 in IFN-α-mediated anti-cancer effects.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...